Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Advanced Principles Of Neural Sciences > Chapter 16: Schizophrenia, Affective Disorders, Anxiety Disorders, And OCD > Flashcards

Chapter 16: Schizophrenia, Affective Disorders, Anxiety Disorders, And OCD Flashcards

1
Q

Schizophrenia

A

Serious mental disorder characterized by disordered thoughts, delusions, hallucinations, and bizarre behaviors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Schizophrenia: Positive Symptoms

A

Presence of unusual behaviors, in excess of typical functioning

- Thought disorders
- Delusions
- Hallucinations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Thought Disorders

A

Disorganized, irrational thinking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Delusions

A

Believe that is clearly contradiction to reality (persecution, grandeur, and control)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hallucinations

A

Perception of nonexistent object or events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Schizophrenia: Negative Symptoms

A

Absence or decrease in some typical behaviors

- Social withdrawal, lack of affect, anhedonia, and reduced motivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Schizophrenia: Cognitive Symptoms

A

Cognitive deficits
- Difficulty sustaining attention, low psychomotor speed, deficits in learning and memory, poor abstract thinking, poor problem solving

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Genetic Factors of Schizophrenia

A
  • Heritability plays a role, but no “schizophrenia gene”
  • Evidence of susceptibility to develop schizophrenia, but triggered by other factors
  • Higher rate in monochorionic monozygotic twins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Schizophrenia Mutations

A

Mutations of DISC1 gene increases likelihood of schizophrenia and other mental disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Schizophrenia Paternal Age

A

Children of older fathers are more likely to develop schizophrenia
- Increased likelihood of mutations in chromosome of cells that produce sperms (mutations in spermatocyte)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Schizophrenia Epigenetic

A
  • Rare mutations of epigenetic factors may predispose people to schizophrenia
  • Methylation leads to suppression of gene
    • DNA is wound more tightly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Epidemiology

A

Study of distribution and causes of diseases in populations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Environmental Factors of Schizophrenia

A
  • Season of birth
  • Viral epidemics
  • Vitamin D deficiency
  • Population density
  • Prenatal stress
  • Substance abuse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Seasonality Effect

A

Increased incident of schizophrenia in people born during late winter and early spring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dopamine hypothesis

A

Positive symptoms of schizophrenia are caused by hyperactivity of dopaminergic synapses in the mesolimbic pathway

- Drugs acting as agonists produce and reinforce positive symptoms
- brain may contain more dopamine receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

D2 receptors and Schizophrenia

A

Increased in people with schizophrenia, but not main reason for schizophrenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Chlorpromazine

A

DA-R blocker antipsychotic drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mesolimbic Dopamine Pathway and Schizophrenia

A
  • Drugs acting as agonists produce and reinforce positive symptoms
  • Some studies show those diagnosed with schizophrenia release excessive dopamine; brains may contain more dopamine receptors
  • Certain thoughts are hijacking the mesolimbic system
    • More DA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Consequences of Long-Term Drug Treatment of Schizophrenia

A
  • Early drugs used for treatment had side effects
    • Parkinson’s-like symptoms
    • Tardive dyskinesia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Tardive Dyskinesia

A

Opposite of Parkinson’s

- involuntary movements of face and neck
- Supersensitivity of D2 receptors in caudate nucleus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Supersensitivity

A

Caused by damage to afferent axons or long-term blockage of NT release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hypofrontality

A

Decreased activity of PFC (especially DLPFC)

- believed to be responsible for negative symptoms
- may also be responsible for hyperactivity in the mesolimbic pathways related to positive symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Atypical Antipsychotics

A

Unlike original antipsychotics, they increase DAergic activity in PFC and reduce it in mesolimbic system
- Aripiprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Clozapine

A

Blocks D4-R in NAc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Aripiprazole
Acts as a partial agonist at DA-R - Increase DA activity in PFC (low DA) - Decrease DA activity in mesolimbic system (high DA)
26
Glutamate hypothesis
Decreased Glu activity (resulting in hypofrontality) may contribute to negative and positive symptoms - Chronic low doses of Glu antagonist drugs produces negative and cognitive symptoms - PCP and ketamine (indirect NMDA antagonists)
27
Developmental Changes Theories in Schizophrenia
1. Abnormalities (suppressed DISC1 expression) in pyramidal neurons of the PFC are primary cause of process that leads to schizophrenia 2. Abnormalities in the striatal DA system are primary causes of process that leads to schizophrenia - result of inhibitory GABAergic transmission in DLPFC
28
Affective Disorders
- Characterized by disorder feelings - Two main types - Bipolar disorder - Major depressive disorder (MDD)
29
Bipolar Disorder
Cyclical periods of mania and depression
30
Major Depressive Disorder (MDD)
Unremitting depression or period of depression that don’t alternate with period of trauma
31
Genetic factors of Affective disorders
- Heritability suggests genetic anomalies | - RORA, GRM8, and RORB genes all have associations with affective disorders
32
Antidepressants
- MAO inhibitors - Tricyclic antidepressants - Selective serotonin reuptake inhibitors (SSRIs) - Serotonin and norepinephrine reuptake inhibitors (SNRIs) - Ketamine - Lithium
33
MAO Inhibitors
5-HT and catecholamines DA, Epi, and NE
34
Tricyclic Antidepressants
Inhibit reuptake of 5-HT and NE
35
Selective Serotonin Reuptake Inhibitors (SSRIs)
Prozac, Celexa, and Paxil
36
Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
- Antagonist action on NAergic transporters | - Milnacipran, duloxetine, and venlafaxine
37
Therapeutic Lag
Period of time between beginning antidepressant treatment and experiencing therapeutic effects - autoreceptor densensitization
38
Ketamine
For treatment resistant depression
39
Treatment resistant depression
MDD whose symptoms aren’t relieved after trials of different treatment methods
40
Lithium
- For bipolar - Taken as LiCO4 - positive response within 1-2 weeks - side effects: hand tremors, weight gain, excessive urine production, and thirst - Eliminates mania - increased gray matter= neural.glial growth
41
Electroconvulsive Therapy
Involves brief electrical shock used to induce a seizure - used to treat mania and depression - decreased brain activity and increased seizure threshold - rapid effects - risk of cognitive impairment or memory loss
42
Vagus Nerve Stimulation
- Indirect form of brain stimulation, but doesn’t induce seizures - Used for treatment-resistant depression
43
Transcranial Magnetic Stimulation
- TMS provides similar benefits to ECT without risk of cognitive impairments or memory loss - Used to treat depression
44
Deep Brain Stimulation
- useful for treatment-resistant depression | - implanted electrodes under subgenual anterior cingulate cortex
45
Subgenual ACC
Focal point in regulation of mood
46
Depressed patients show hyperactivity of […] along with decreased activity in […]
Depressed patients show hyperactivity of subgenual ACC along with decreased activity in DLPFC. VLPFC, VMPFC, and orbitofrontal cortex
47
Monoamine Hypothesis
Depression is caused by insufficient activity of monoaminergic neurons - roles of norepinephrine and 5-HT
48
Tryptophan Depletion Procedure
Procedure involved low-Trp diet and Trp-free amino acid “cocktail” that lowers brain Trp and decrease synthesis of 5-HT - Depletion of Trp in brain causes recurrence of depressive symptoms - 5-HT plays a role in mood, although exact nature is unknown
49
5-HT transporter and depression
- stressful life events increase probability of depression for those with 1-2 copies of short alleles for 5-HTT promoter - less likely to respond to treatment
50
Neurogenesis and Depression
- Stress and depression are associated with reduced hippocampal neurogenesis (dentate gyrus) - Antidepressant treatment increases hippocampal neurogenesis in lab animals
51
Exercise and Neurogenesis
Increased blood volume in dentate gyrus leads to neurogenesis
52
Circadian Rhythms and Depression
- Sleep disturbances - Sleep deprivation can reduce depression in some people - Seasonal affective disorder
53
Seasonal Affective Disorder
Mood disorder characterized by depression, lethargy, sleep disturbances, and craving for carbs during winter season when days are short - can be treated by phototherapy - genetic basis: allele of gene responsible for production of melanopsin
54
Phototherapy
Treatment of SAD by daily exposure to bright light
55
Sleep and Depression
Reduced sleep latency, reduced REM latency, lack of slow-wave sleep, and general fragmentation of sleep
56
Anxiety Disorders
- Characterized by unrealistic, unfounded fear and anxiety - Most common psychiatric disorder - Overactive ANS - Panic disorder - Generalized anxiety disorder - Social anxiety disorder
57
Panic Disorder
Episodic attacks of acute anxiety - Anticipatory Anxiety - Agoraphobia
58
Anticipatory Anxiety
Fear of having panic attack
59
Agoraphobia
Fear of being away from home or other protected places
60
Generalized Anxiety Disorder
Excessive anxiety and worry serious enough to cause disruption of person’s life
61
Social Anxiety Disorder
Excessive fear of being exposed to scrutiny of other people that leads to avoidance of social situations in which person is called on to perform
62
Anxiety and Genetic Factors
- Genes for BDNF protein likely play a role
63
Anxiety Biology
- Increased activation of amygdala | - Decreased of VLPFC
64
BDNF
Neuronal survival and differentiation during development and LYP
65
Amygdala and vmPFC: Anxiety
Adolescents with generalized anxiety disorder show increased activation amygdala and decreased activation of vmPFC - vmPFC-role in extinction and inhibition of fear and anxiety
66
Anxiety Pharmacological Treatment
- Benzodiazepines | - SSRIs
67
Benzodiazepines: Anxiety
- Bind to GABAa-R - Fast acting; often used for emergency treatment - Less appropriate for long-term treatment
68
SSRIs: Anxiety
- Preferred treatment option | - Used in conjunction with cognitive behavior therapy
69
Obsessive-Compulsive Disorder
- Individuals experience unwanted thoughts and uncontrollable behaviors - Commonly begin in young adulthood - Four categories: counting, checking, cleaning, and avoidance
70
Obsession
Unwanted thought or idea with which person is preoccupied | - also seen in schizophrenia
71
Compulsion
Feeling that one is obliged to perform a behavior
72
OCD Genetics
Heredity plays a role
73
OCD Environment
- Brain damage at birth, encephalitis, and head trauma - Group A b-hemolytic infection - Autoimmune disorder
74
Brain changes OCD
- Damage to the basal ganglia, cingulate gyrus or PFC - There was an increase in size to the basal ganglia for those with b-hemolytic streptococcus - Increased activity of frontal lobe and caudate nucleus in those with OCD
75
OCD Drug Therapies
Serotonergic agonists such as clomipramine, fluoxetine, and fluvoxamine used for treating OCD - Clomipramine also used for three other compulsions - Symptoms relieved by increasing the activity of serotonergic pathways with inhibitory role in behaviors
76
Deep Brain Stimulation: OCD
DBS in basal ganglia or subthalamic nucleus
77
Serotonin can be seen in 3 different compulsions
Trichotillomania, onychophagia, and actual lick dermatitis

Advanced Principles Of Neural Sciences (15 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions